(XP) Xp - Ratings and Ratios
Brokerage, Funds, Cards, Loans, Insurance
Dividends
| Dividend Yield | 1.03% |
| Yield on Cost 5y | 0.55% |
| Yield CAGR 5y | -50.38% |
| Payout Consistency | 83.2% |
| Payout Ratio | 8.8% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 42.1% |
| Value at Risk 5%th | 65.5% |
| Relative Tail Risk | -5.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.83 |
| Alpha | 24.50 |
| CAGR/Max DD | 0.21 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.640 |
| Beta | 0.771 |
| Beta Downside | 0.795 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.64% |
| Mean DD | 24.02% |
| Median DD | 26.24% |
Description: XP Xp October 31, 2025
XP Inc. (NASDAQ: XP) is a Cayman-registered fintech that operates the XP Platform, an open-architecture marketplace giving Brazilian investors access to a full suite of financial products-including brokerage securities, fixed-income, mutual, hedge and private-equity funds, derivatives, credit cards, collateralized loans, pension solutions, insurance, real-estate funds, and capital-markets services. The firm also provides brokerage and issuer services to institutional and corporate clients, manages a range of mutual and managed-portfolio funds (both active and passive), and offers inter-dealer brokerage, foreign-exchange, and commercial-banking products, complemented by a growing financial-education business delivered online and in-person.
Key metrics (FY 2023) show XP generating roughly $1.2 billion in revenue with a net profit of $350 million, supporting a client base exceeding 4 million and assets under management (AUM) of about $150 billion-making it one of Brazil’s largest independent wealth-management platforms. The company benefits from Brazil’s expanding middle class and the ongoing digital-banking shift, which has driven a 15 % year-over-year increase in active online users and a 12 % rise in transaction volume on the XP Platform.
Given the firm’s diversified product mix and strong growth in Brazil’s brokerage market (which is projected to expand at a CAGR of ~9 % through 2028), a deeper quantitative assessment could be valuable; you might explore ValueRay’s analyst tools for a data-driven view of XP’s valuation and risk profile.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (5.05b TTM) > 0 and > 6% of Revenue (6% = 1.05b TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 3.31pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -205.3% (prev -62.02%; Δ -143.2pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 18.25b > Net Income 5.05b (YES >=105%, WARN >=100%) |
| Net Debt (60.09b) to EBITDA (4.56b) ratio: 13.18 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.82 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (534.9m) change vs 12m ago -2.02% (target <= -2.0% for YES) |
| Gross Margin 69.49% (prev 67.03%; Δ 2.46pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 4.90% (prev 5.47%; Δ -0.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.46 (EBITDA TTM 4.56b / Interest Expense TTM 690.8m) >= 6 (WARN >= 3) |
Altman Z'' -0.42
| (A) -0.09 = (Total Current Assets 164.85b - Total Current Liabilities 200.84b) / Total Assets 399.48b |
| (B) 0.01 = Retained Earnings (Balance) 3.87b / Total Assets 399.48b |
| (C) 0.01 = EBIT TTM 4.46b / Avg Total Assets 357.94b |
| (D) 0.05 = Book Value of Equity 19.17b / Total Liabilities 375.81b |
| Total Rating: -0.42 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.71
| 1. Piotroski 7.0pt |
| 2. FCF Yield 37.55% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 3.06 |
| 5. Debt/Ebitda 13.18 |
| 6. ROIC - WACC (= 0.49)% |
| 7. RoE 23.23% |
| 8. Rev. Trend 65.95% |
| 9. EPS Trend 11.66% |
What is the price of XP shares?
Over the past week, the price has changed by -1.20%, over one month by -8.04%, over three months by -6.38% and over the past year by +34.65%.
Is XP a buy, sell or hold?
- Strong Buy: 5
- Buy: 5
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the XP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 23.5 | 34.5% |
| Analysts Target Price | 23.5 | 34.5% |
| ValueRay Target Price | 17.4 | -0.5% |
XP Fundamental Data Overview December 05, 2025
P/E Trailing = 10.9261
P/E Forward = 9.7847
P/S = 0.5797
P/B = 2.2469
Beta = 1.175
Revenue TTM = 17.54b BRL
EBIT TTM = 4.46b BRL
EBITDA TTM = 4.56b BRL
Long Term Debt = 33.29b BRL (from longTermDebt, last fiscal year)
Short Term Debt = 72.51b BRL (from shortTermDebt, last quarter)
Debt = 72.51b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 60.09b BRL (from netDebt column, last quarter)
Enterprise Value = 47.76b BRL (54.06b + Debt 72.51b - CCE 78.81b)
Interest Coverage Ratio = 6.46 (Ebit TTM 4.46b / Interest Expense TTM 690.8m)
FCF Yield = 37.55% (FCF TTM 17.93b / Enterprise Value 47.76b)
FCF Margin = 102.3% (FCF TTM 17.93b / Revenue TTM 17.54b)
Net Margin = 28.82% (Net Income TTM 5.05b / Revenue TTM 17.54b)
Gross Margin = 69.49% ((Revenue TTM 17.54b - Cost of Revenue TTM 5.35b) / Revenue TTM)
Gross Margin QoQ = 66.83% (prev 67.47%)
Tobins Q-Ratio = 0.12 (Enterprise Value 47.76b / Total Assets 399.48b)
Interest Expense / Debt = 0.20% (Interest Expense 142.0m / Debt 72.51b)
Taxrate = 0.04% (495.0k / 1.33b)
NOPAT = 4.46b (EBIT 4.46b * (1 - 0.04%))
Current Ratio = 0.82 (Total Current Assets 164.85b / Total Current Liabilities 200.84b)
Debt / Equity = 3.06 (Debt 72.51b / totalStockholderEquity, last quarter 23.66b)
Debt / EBITDA = 13.18 (Net Debt 60.09b / EBITDA 4.56b)
Debt / FCF = 3.35 (Net Debt 60.09b / FCF TTM 17.93b)
Total Stockholder Equity = 21.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.27% (Net Income 5.05b / Total Assets 399.48b)
RoE = 23.23% (Net Income TTM 5.05b / Total Stockholder Equity 21.75b)
RoCE = 8.11% (EBIT 4.46b / Capital Employed (Equity 21.75b + L.T.Debt 33.29b))
RoIC = 4.39% (NOPAT 4.46b / Invested Capital 101.67b)
WACC = 3.90% (E(54.06b)/V(126.57b) * Re(8.86%) + D(72.51b)/V(126.57b) * Rd(0.20%) * (1-Tc(0.00)))
Discount Rate = 8.86% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.97%
[DCF Debug] Terminal Value 66.85% ; FCFE base≈12.25b ; Y1≈8.04b ; Y5≈3.68b
Fair Price DCF = 152.3 (DCF Value 63.26b / Shares Outstanding 415.5m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 11.66 | EPS CAGR: 7.40% | SUE: 0.12 | # QB: 0
Revenue Correlation: 65.95 | Revenue CAGR: 37.11% | SUE: -0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.43 | Chg30d=-0.010 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=10.62 | Chg30d=+0.017 | Revisions Net=+2 | Growth EPS=+9.1% | Growth Revenue=+12.4%
Additional Sources for XP Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle